EP3328416
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.8.2016EP published:
13.3.2024EP application number:
16750584.1
EPO information:
European Patent Register
Max expiry date:
31.7.2036
Title in English:
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIALanguage of the patent:
English
Timeline
Today
1.8.2016EP application
13.3.2024EP Publication
Owner
Name:
BioMarin Pharmaceutical Inc.Address:
105 Digital Drive, Novato, CA 94949, US
Inventor
Name:
BULLENS, SherryAddress:
Novato, CA 94949, US
Name:
BUNTING, StuartAddress:
Novato, CA 94949, US
Name:
CHOU, TianweiAddress:
Novato, CA 94949, US
Name:
OKHAMAFE, Augustus, O.Address:
Concord, CA 94521, US
Name:
PRICE, Christopher, P.Address:
52070 Aachen, DE
Name:
WENDT, Daniel, J.Address:
Novato, CA 94949, US
Name:
YAP, ClarenceAddress:
Novato, CA 94949, US
Priority
Number:
201562199081 PDate:
30.7.2015Country:
US
Number:
201662320704 PDate:
11.4.2016Country:
US
Classification
Categories:
A61K 9/00, A61K 9/19, A61K 38/17, A61K 38/22, A61K 47/12, A61K 47/20, A61K 47/26, A61P 19/08